Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response.
Walker AJ, Mohebbi M, Maes M, Berk M, Walder K, Bortolasci CC, Liu ZS, Ng CH, Ashton MM, Berk L, Singh AB, Malhi GS, Dean OM. Walker AJ, et al. Among authors: bortolasci cc. Brain Behav Immun Health. 2022 Dec 24;27:100581. doi: 10.1016/j.bbih.2022.100581. eCollection 2023 Feb. Brain Behav Immun Health. 2022. PMID: 36632339 Free PMC article.
Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder.
Bortolasci CC, Vargas HO, Souza-Nogueira A, Barbosa DS, Moreira EG, Nunes SO, Berk M, Dodd S, Maes M. Bortolasci CC, et al. J Affect Disord. 2014 Apr;159:23-30. doi: 10.1016/j.jad.2014.02.018. Epub 2014 Feb 19. J Affect Disord. 2014. PMID: 24679385
Association of paraoxonase (PON)1 activity, glutathione S-transferase GST T1/M1 and STin.2 polymorphisms with comorbidity of tobacco use disorder and mood disorders.
Vargas Nunes SO, Pizzo de Castro MR, Moreira EG, Guembarovski RL, Barbosa DS, Vargas HO, Piccoli de Melo LG, Bortolasci CC, Watanabe MA, Dodd S, Berk M, Maes M. Vargas Nunes SO, et al. Among authors: bortolasci cc. Neurosci Lett. 2015 Jan 12;585:132-7. doi: 10.1016/j.neulet.2014.11.002. Epub 2014 Nov 6. Neurosci Lett. 2015. PMID: 25445355
Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways.
de Farias CC, Maes M, Bonifacio KL, Matsumoto AK, Bortolasci CC, Nogueira AS, Brinholi FF, Morimoto HK, de Melo LB, Moreira EG, Barbosa DS. de Farias CC, et al. Among authors: bortolasci cc. CNS Neurol Disord Drug Targets. 2017;16(4):484-491. doi: 10.2174/1871527316666170223161004. CNS Neurol Disord Drug Targets. 2017. PMID: 28240188
Oxidative and nitrosative stress biomarkers in chronic schizophrenia.
Boll KM, Noto C, Bonifácio KL, Bortolasci CC, Gadelha A, Bressan RA, Barbosa DS, Maes M, Moreira EG. Boll KM, et al. Among authors: bortolasci cc. Psychiatry Res. 2017 Jul;253:43-48. doi: 10.1016/j.psychres.2017.03.038. Epub 2017 Mar 21. Psychiatry Res. 2017. PMID: 28346888
63 results